House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.
Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.
Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees.
Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.
Hurricane Katrina: Cancer groups, NCI offer help to displaced patients and caregivers.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
